Home  |  About GZ  |  Directory  |  Contact Us  |  Help Center
Government  |  Residents  |  Visitors  |  Business  
简体版   
City news
China, Singapore strengthen cooperation in cancer prevention, treatment
Update: 2024-03-01     Source: GDToday

On February 28, the China-Singapore Guangzhou Knowledge City witnessed the inauguration of the China-Singapore Technology Innovation and Translational Medicine Center for Tumor Prevention and Treatment (TMC). 

The China-Singapore Technology Innovation and Translational Medicine Center for Tumor Prevention and Treatment (TMC) is inaugurated in the China-Singapore Guangzhou Knowledge City.

This center, jointly established by Biosyngen and KCI Group, plays a significant role in providing a platform and serving as an innovation model for China-Singapore cooperation. The establishment of the TMC will effectively promote cooperation between the two countries in the field of cancer prevention and treatment.

The TMC is committed to building an open innovation platform for medical transformation in the field of cell and gene therapy. Its goal is to connect governmental organizations, hospitals, supply chains, and various stakeholders in the ecosystem. By integrating research, development, and production into a comprehensive industrial chain layout, the TMC aims to achieve clinical transformation and industrialization.

Loh Tuck Keat, Consul General of Singapore in Guangzhou, remarked, "The TMC cooperation between the two countries in the fields of innovation and science and technology will bring tangible mutual benefits to the people of China and Singapore."

Loh Tuck Keat, Consul General of Singapore in Guangzhou, delivers a speech.

As of now, the Knowledge City has attracted 96 Singaporean enterprises, with a total investment of nearly 18.5 billion RMB, highlighting its status as a hub for innovation and collaboration between China and Singapore.

Biosyngen was established in Singapore in 2016. As one of the first Singaporean companies to settle in the Knowledge City in 2017, it currently has four innovative drugs that will be launched on the market.

The experimenter is taking samples for testing. 

All materials marked with "source: English.gz.gov.cn" on this website (including but not limited to text, photographs, audio and video materials) are the copyrighted property of Guangzhou International (the official website of Guangzhou Municipality). Without prior authorization from Guangzhou International, any media, website, organization or individual shall not transmit, interlink, distribute or republish such materials in any form. Any media and website authorized to republish such materials shall mark them with "source: Guangzhou International (English.gz.gov.cn)". Infringement of these copyrights will result in legal action.

If you find out anything wrong with the information, links and the translation, please offer your comments by selecting the relative content with your mouse and holding "CTRL" and "ENTER" simultaneously. Thank you!
Copyright © 2010 The People`s Government of Guangzhou Municipality.All RightsReserved
Email: gzportal@gz.gov.cn ICP备案号: 粤ICP备2022092331号-1